Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | -10.52% | -4.66% | +100.00% |
06/05 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
10/04 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+100.00% | 1.45Cr | |
+18.72% | 12TCr | |
+14.19% | 11TCr | |
-4.93% | 2.42TCr | |
+3.23% | 2.28TCr | |
-10.44% | 1.8TCr | |
-41.74% | 1.64TCr | |
-13.31% | 1.64TCr | |
+2.44% | 1.36TCr | |
+27.89% | 1.17TCr |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Chemomab Therapeutics Ltd. Names Donald R. Marvin, Executive Vice President and Chief Operating Officer